Austin, Texas — According to state and local economic development sources Worldwide Clinical Trials plans to invest $2,100,000.00 to build out 14,342 square feet of new space in Austin. The company plans to occupy the new space at 4509 Freidrich Lane Suite 200 in Austin, on or about August 1, 2022. According to the company website Worldwide Clinical Trials is a global, mid sized, Contract Research Organization (CRO) that provides top performing, preclinical, and Phase I IV clinical development services to the biotechnology and pharmaceutical industries. Founded in 1986 by physicians committed to advancing medical science, our full service clinical experience ranges from early phase and bioanalytical sciences through late phase studies, post approval, and real world evidence. Major therapeutic areas of focus include Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases. With infrastructure spanning 60 countries and offices in North and South America, Eastern and Western Europe, Russia and Asia, Worldwide is powered by its more than 2,600 employee experts.

To learn more about Worldwide Clinical Trials, visit http://www.worldwide.com/

Company Contact:
Michael Murphy, Chief Medical Officer
https://www.linkedin.com/in/michael-murphy-m-d-ph-d-36a68237/
610-964-2000

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved